Rare diseases
Investigational molecules
Locations
Back to Poland13 clinical trials in Checiny, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study
PolandStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
PolandA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
PolandStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
PolandStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
PolandStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy comparing fluticasone furoate and vilanterol inhalation powder with BREO ELLIPTA in adults with asthma to evaluate their therapeutic equivalence and safety
PolandStudy on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment
PolandA Study of Depemokimab and Prednisolone in Adults with Hypereosinophilic Syndrome (HES)
PolandStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
PolandStudy on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical studies focusing on severe asthma management and new therapeutic approaches. Research includes evaluation of novel treatments like lunsekimig and tezepelumab for patients with difficult-to-control asthma symptoms.
These trials aim to improve treatment options for patients dependent on oral corticosteroids and those with severe asthma manifestations.
Groundbreaking research investigating treatments for Hypereosinophilic Syndrome (HES), with particular focus on benralizumab's potential therapeutic benefits in managing this rare condition.
The research aims to establish effective interventions for this challenging hematologic disorder.
Comprehensive studies examining chronic obstructive pulmonary disease treatments, including evaluation of triple therapy combinations and new delivery systems for established medications.
These trials focus on improving lung function and reducing exacerbation frequency in moderate to severe COPD patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
